FOCAL SEIZURE
Clinical trials for FOCAL SEIZURE explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEIZURE trials appear
Sign up with your email to follow new studies for FOCAL SEIZURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New epilepsy drug vormatrigine tested for Long-Term safety in 700 adults
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety of a once-daily drug called vormatrigine in 700 adults with focal or generalized tonic-clonic seizures. Participants must have already taken vormatrigine in a previous trial or program. The main goal is to check for side effects and chan…
Matched conditions: FOCAL SEIZURE
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New epilepsy drug candidate iQ-007 enters first human safety trial
Knowledge-focused OngoingThis early-stage trial tests the safety of an experimental oral drug called iQ-007 in 72 healthy volunteers. The drug is designed to help control seizures by boosting the brain's ability to clear excess glutamate, a chemical linked to epilepsy. The study does not yet test if it w…
Matched conditions: FOCAL SEIZURE
Phase: PHASE1 • Sponsor: iQure Australia Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC